Sarcoidosis during infliximab therapy for Crohn's disease

被引：22

作者：

Takahashi, Hidetoshi ^{[1
]}

Kaneta, Kazuhiro ^{[1
]}

Honma, Masaru ^{[1
]}

Ishida-Yamamoto, Akemi ^{[1
]}

Ashida, Tomonori ^{[2
]}

Kohgo, Yutaka ^{[2
]}

Ohsaki, Yoshinobu ^{[3
]}

Iizuka, Hajime ^{[1
]}

机构：

[1] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan

[2] Asahikawa Med Coll, Dept Internal Med 3, Asahikawa, Hokkaido 0788510, Japan

[3] Asahikawa Med Coll, Dept Internal Med 1, Asahikawa, Hokkaido 0788510, Japan

来源：

JOURNAL OF DERMATOLOGY | 2010年 / 37卷 / 05期

关键词：

infliximab; psoriasiform eruption; tumor necrosis factor-alpha; TUMOR-NECROSIS-FACTOR; PULMONARY SARCOIDOSIS; ETANERCEPT THERAPY; ARTHRITIS; PATIENT;

D O I：

10.1111/j.1346-8138.2010.00861.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Tumor necrosis factor-alpha (TNF-alpha) antagonists are effective for inflammatory diseases, such as Crohn's disease, rheumatoid arthritis (RA) and psoriasis. Although TNF-alpha antagonists are also useful for sarcoidosis, paradoxical occurrence of sarcoidosis or sarcoidal reaction may be observed. We report a Crohn's disease patient, who developed sarcoidosis during infliximab therapy. A 35-year-old man had been receiving infliximab for 7 months for Crohn's disease. He developed cough and fever, accompanied by an infiltrated erythematous plaque on his right knee. The chest radiography, skin biopsy and laboratory findings were all consistent with sarcoidosis.

引用

页码：471 / 474

页数：4

共 50 条

[31] Time of infliximab therapy initiation and dose escalation in Crohn's disease [J].

Lam, Mindy C. W. ;

Lee, Terry ;

Atkinson, Kenneth ;

Bressler, Brian .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) :214-218

[32] Azathioprine and Infliximab: Monotherapy or Combination Therapy in the Treatment of Crohn's Disease [J].

Love, Bryan L. ;

Smith, Lisa S. ;

Sarbah, Steedman A. ;

Fowler, Fred C. .

CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2011, 4 :21-30

[33] Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease [J].

Cottone, Mario ;

Papi, Claudio ;

Orlando, Ambrogio .

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (06) :709-712

[34] Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B [J].

Ueno, Y ;

Tanaka, S ;

Shimamoto, M ;

Miyanaka, Y ;

Hiyama, T ;

Ito, M ;

Kitadai, Y ;

Yoshihara, M ;

Sumii, M ;

Chayama, K .

DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (01) :163-166

[35] Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B [J].

Yoshitaka Ueno ;

Shinji Tanaka ;

Masaru Shimamoto ;

Yoshihiro Miyanaka ;

Toru Hiyama ;

Masanori Ito ;

Yasuhiko Kitadai ;

Masaharu Yoshihara ;

Masaharu Sumii ;

Kazuaki Chayama .

Digestive Diseases and Sciences, 2005, 50 :163-166

[36] Large paraspinal abscess as a complication of infliximab therapy in Crohn's disease [J].

Nithianandan, Nishani ;

Loftus, Michael J. ;

Johnson, Paul D. R. ;

Charles, Patrick G. P. .

BMJ CASE REPORTS, 2019, 12 (04)

[37] Comparison of Infliximab and Infliximab/Azathioprine for Maintenance Therapy in Korean Patients with Luminal Crohn's Disease [J].

Won, Hyun Sun ;

Park, Dong Il ;

Chon, Chang Uk ;

Seok, Hyo Sun ;

Kim, Tae Wan ;

Heo, Woon Je ;

Lee, Chang Kyun ;

Eun, Chang Soo ;

Han, Dong Soo ;

Lee, Suck-Ho .

INTESTINAL RESEARCH, 2011, 9 (03) :189-195

[38] Infliximab treatment of rheumatoid arthritis and Crohn's disease [J].

Nahar, IK ;

Shojania, K ;

Marra, CA ;

Alamgir, AH ;

Anis, AH .

ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) :1256-1265

[39] Infliximab use in Crohn's disease [J].

Bewtra, M ;

Lichtenstein, GR .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) :589-599

[40] Treatment of Crohn's disease with infliximab [J].

Garnett, WR ;

Yunker, N .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (04) :307-316

← 1 2 3 4 5 →